Vincent Medical (HKG:1612) expects an attributable profit of at least HK$50 million for the six months ended June 30, up over 50% from HK$33.3 million a year prior, a Thursday Hong Kong bourse filing said.

The medical device maker attributed the anticipated higher profit mainly to an increase in revenue amid a boost in sales orders from the imaging disposable products segment, as well as an improved gross profit margin.